Home>Hepcinat-LP>hepcinat-lp tablet

Hepcinat-LP Tablet

icon
iconPrescription Required

Primary uses of Hepcinat-LP Tablet

Chronic hepatitis C virus (HCV) infection
MRP
18500
₹660.71/Tablet
28 tablets in 1 strip
ADD TO CART
Online payment only

Medicine Overview of Hepcinat-LP Tablet

uses

Uses of Hepcinat-LP Tablet

Hepcinat-LP Tablet is used in the treatment of chronic hepatitis C virus (HCV) infection.
uses

Hepcinat-LP Tablet side effects

Common

Tiredness, Headache.

uses

How to use Hepcinat-LP Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Hepcinat-LP Tablet may be taken with or without food, but it is better to take it at a fixed time.

How Hepcinat-LP Tablet works

Hepcinat-LP Tablet is a combination of two antiviral medicines: Ledipasvir and Sofosbuvir. They work by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time.

In Depth Information on Hepcinat-LP Tablet

Hepcinat-LP Tablet related warnings
Special precautions for Hepcinat-LP Tablet
Alcohol
Interaction with alcohol is unknown. Please consult your doctor.
Pregnancy
PROBABLY SAFE
Hepcinat-LP Tablet is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Lactation
Hepcinat-LP Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Driving
Do not drive unless you are feeling well.
Hepcinat-LP Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive.
Kidney
Hepcinat-LP Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Hepcinat-LP Tablet may be needed. Please consult your doctor.
Limited information is available on use of Hepcinat-LP Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Liver
SAFE
Hepcinat-LP Tablet is safe to use in patients with liver disease. No dose adjustment of Hepcinat-LP Tablet is recommended.

Patient Concerns

No Patient Concerns found for this medicine

User Submitted Feedback For Hepcinat-LP Tablet

Survey Participants: 11
Disclaimer
“The following are the results of on-going survey on 1mg.com for Hepcinat-LP Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Hepcinat-LP Tablet: HEX, RKS, RDH, RHL, ENP, AAR, DGN, SSA, TFP, WSI, UMP, ATP, HAT, BMJ, RHW, MDH, HGI, DLP, DVH, VNS, HZF, OHM, NVY, SGC, LCC, RJH, NVL, HTS, BHP, RPP, MAK, BHM, HSP, RPI, PMA, ZVP, SCH, GTK, PPR, JIV, DHR, SHC, ATL, P2P, TNH, EMB, MLC, GHR, IAD, PTI, SLN, DFP, RSS, AMR, GTC, PEN, DPL, BAP, NTB, FGH, MPC, ESY, OWP, BLE, SAF, SWA, RDR, NXG, IPL, SYN, PLT, VDH, BDN, PNT, SGH, DYG, RWP, DPP, BSN, ABP, WHL, PWN, JSL, VRS, NSL, RSA, SHD, GBL, BBS, GPP, OIP, OLT, ADT, KHC, USF, AAY, NNH, GPT, KHH, TOM, KMC, 9T9, PRN, BIO, HIP, SDM, SRG, STA, SJP, EVP, QLF, MMS, MAM, LHA, MAX, INC, GNC, ANT, JVN, BAL, THP, HMP, MSD, HPC, PVP, JVO, MDO, HBV, BTM, ARD, RUS, QTM, CLT, HNP, SVH, SBA, TRP, AGT, AYM, SBL, ZEL, EQN, NDP, SWP, SHP, AYU
cross img